Cost of severe hypoglycaemia in patients with type 1 diabetes in Spain and the cost-effectiveness of insulin lispro compared with regular human insulin in preventing severe hypoglycaemia

OBJECTIVES: To determine the costs of severe hypoglycaemia (SH) in a population of patients with type 1 diabetes mellitus in the Spanish healthcare system and the cost-effectiveness of insulin lispro over regular insulin in preventing SH episodes. METHODS: A retrospective study of 100 patients in th...

Descripción completa

Detalles Bibliográficos
Autores principales: Reviriego, J, Gomis, R, Marañés, J P, Ricart, W, Hudson, P, Sacristán, J A
Formato: Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2008
Materias:
Endocrinology & Metabolism
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2438603/
https://www.ncbi.nlm.nih.gov/pubmed/18489577
http://dx.doi.org/10.1111/j.1742-1241.2008.01783.x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2438603/
https://www.ncbi.nlm.nih.gov/pubmed/18489577
http://dx.doi.org/10.1111/j.1742-1241.2008.01783.x

Ejemplares similares